These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 37583655

  • 1. Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
    Alesi S, Forslund M, Melin J, Romualdi D, Peña A, Tay CT, Witchel SF, Teede H, Mousa A.
    EClinicalMedicine; 2023 Sep; 63():102162. PubMed ID: 37583655
    [Abstract] [Full Text] [Related]

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 3. Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: A systematic review with meta-analyses.
    Teede H, Tassone EC, Piltonen T, Malhotra J, Mol BW, Peña A, Witchel SF, Joham A, McAllister V, Romualdi D, Thondan M, Costello M, Misso ML.
    Clin Endocrinol (Oxf); 2019 Oct 01; 91(4):479-489. PubMed ID: 31087796
    [Abstract] [Full Text] [Related]

  • 4. Interventions for hirsutism (excluding laser and photoepilation therapy alone).
    van Zuuren EJ, Fedorowicz Z, Carter B, Pandis N.
    Cochrane Database Syst Rev; 2015 Apr 28; 2015(4):CD010334. PubMed ID: 25918921
    [Abstract] [Full Text] [Related]

  • 5. Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis.
    Forslund M, Melin J, Alesi S, Piltonen T, Romualdi D, Tay CT, Witchel S, Pena A, Mousa A, Teede H.
    Eur J Endocrinol; 2023 Jul 20; 189(1):S1-S16. PubMed ID: 37440702
    [Abstract] [Full Text] [Related]

  • 6. Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis.
    Melin J, Forslund M, Alesi S, Piltonen T, Romualdi D, Spritzer PM, Tay CT, Pena A, Witchel SF, Mousa A, Teede H.
    J Clin Endocrinol Metab; 2024 Jan 18; 109(2):e817-e836. PubMed ID: 37554096
    [Abstract] [Full Text] [Related]

  • 7. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
    Naderpoor N, Shorakae S, de Courten B, Misso ML, Moran LJ, Teede HJ.
    Hum Reprod Update; 2015 Jan 18; 21(5):560-74. PubMed ID: 26060208
    [Abstract] [Full Text] [Related]

  • 8. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome.
    Fraison E, Kostova E, Moran LJ, Bilal S, Ee CC, Venetis C, Costello MF.
    Cochrane Database Syst Rev; 2020 Aug 13; 8(8):CD005552. PubMed ID: 32794179
    [Abstract] [Full Text] [Related]

  • 9. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE), Androgen Excess and PCOS Society (AES).
    Endocr Pract; 2015 Nov 13; 21(11):1291-300. PubMed ID: 26509855
    [Abstract] [Full Text] [Related]

  • 10. Combined oral contraceptives and/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis.
    Luque-Ramírez M, Nattero-Chávez L, Ortiz Flores AE, Escobar-Morreale HF.
    Hum Reprod Update; 2018 Mar 01; 24(2):225-241. PubMed ID: 29293982
    [Abstract] [Full Text] [Related]

  • 11. Ovarian surgery for symptom relief in women with polycystic ovary syndrome.
    Lepine S, Jo J, Metwally M, Cheong YC.
    Cochrane Database Syst Rev; 2017 Nov 10; 11(11):CD009526. PubMed ID: 29125183
    [Abstract] [Full Text] [Related]

  • 12. Impact of pharmacological interventions on biochemical hyperandrogenemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
    Abdalla MA, Shah N, Deshmukh H, Sahebkar A, Östlundh L, Al-Rifai RH, Atkin SL, Sathyapalan T.
    Arch Gynecol Obstet; 2023 May 10; 307(5):1347-1376. PubMed ID: 35434762
    [Abstract] [Full Text] [Related]

  • 13. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.
    Costello M, Shrestha B, Eden J, Sjoblom P, Johnson N.
    Cochrane Database Syst Rev; 2007 Jan 24; (1):CD005552. PubMed ID: 17253562
    [Abstract] [Full Text] [Related]

  • 14. SPIOMET4HEALTH-efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial.
    Garcia-Beltran C, Malpique R, Andersen MS, Bas F, Bassols J, Darendeliler F, Díaz M, Dieris B, Fanelli F, Fröhlich-Reiterer E, Gambineri A, Glintborg D, López-Bermejo A, Mann C, Marin S, Obermayer-Pietsch B, Ødegård R, Ravn P, Reinehr T, Renzulli M, Salvador C, Singer V, Vanky E, Torres JV, Yildiz M, de Zegher F, Ibáñez L.
    Trials; 2023 Sep 15; 24(1):589. PubMed ID: 37715279
    [Abstract] [Full Text] [Related]

  • 15. Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: A systematic review.
    Forslund M, Melin J, Alesi S, Piltonen T, Romualdi D, Tay CT, Witchel S, Pena A, Mousa A, Teede H.
    Clin Endocrinol (Oxf); 2023 Jul 15; 99(1):79-91. PubMed ID: 36939017
    [Abstract] [Full Text] [Related]

  • 16. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study.
    Koch T, Doherty DA, Dickinson JE, Juul A, Hart R, Bräuner EV, Hickey M.
    Psychoneuroendocrinology; 2021 Mar 15; 125():105104. PubMed ID: 33352473
    [Abstract] [Full Text] [Related]

  • 17. Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials.
    Almalki HH, Alshibani TM, Alhifany AA, Almohammed OA.
    BMC Womens Health; 2020 Apr 05; 20(1):68. PubMed ID: 32248801
    [Abstract] [Full Text] [Related]

  • 18. Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis.
    Zeng H, Zhang Y, Huang S, Wu J, Ren W, Zhou L, Huang L, Ye Y.
    Front Endocrinol (Lausanne); 2023 Apr 05; 14():1223768. PubMed ID: 37635987
    [Abstract] [Full Text] [Related]

  • 19. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.
    J Clin Endocrinol Metab; 2000 Aug 05; 85(8):2767-74. PubMed ID: 10946879
    [Abstract] [Full Text] [Related]

  • 20. Lifestyle changes in women with polycystic ovary syndrome.
    Moran LJ, Hutchison SK, Norman RJ, Teede HJ.
    Cochrane Database Syst Rev; 2011 Feb 16; (2):CD007506. PubMed ID: 21328294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.